CAS number
CAS 57966-95-7 cymoxanil (ISO)
CAS 57966-95-7 · CAS 166900-80-7 · EC 261-043-0 · Index No 616-035-00-5
Where CAS 57966-95-7 appears: every table entry that prints it among its identifiers, in the newest version of each act this record holds, and every recorded change to those entries. Many entries name a group of substances and print no number, so absence here is not absence from the law. Not legal advice.
Where it appears now
CLP Annex VI section 3, Index No 616-035-00-5
Last changed in the version in force , by Regulation (EU) 2024/197, the act that change names · Annex VI on this site
| Index No | Chemical name | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors and ATEs | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||
| 616-035-00-5 | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [1] (2E)-2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [2] | 261-043-0 [1] - [2] | 57966-95-7 [1] 166900-80-7 [2] | Repr. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361fd H302 H373 (blood system, thymus, eyes) H317 H400 H410 | GHS08 GHS07 GHS09 Wng | H361fd H302 H373 (blood system, thymus, eyes) H317 H410 | oral: ATE = 360 mg/kg bw M = 1 M = 1 | ||
CLP Annex VI section 3, table 2, Index No 616-035-00-5
Last changed in the version in force , by Regulation (EU) No 1297/2014 and Regulation (EU) No 605/2014, the acts that change names · Annex VI on this site
| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
|---|---|---|---|---|---|---|---|
| 616-035-00-5 | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 261-043-0 | 57966-95-7 | Repr. Cat. 3; R62-63 Xn; R22-48/22 R43 N; R50-53 | Xn; N R: 22-43-48/22-62-63-50/53 S: (2-)36/37-46-60-61 | N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % |
Cosmetics Regulation Annex II, Reference number 1580
Last changed in the version in force , by Regulation (EU) 2025/877, the act that change names · Annex II on this site
| Reference number | Substance identification | ||
|---|---|---|---|
| Chemical name/INN | CAS number | EC number | |
| a | b | c | d |
| 1580 | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [1] | 57966-95-7; [1] | 261-043-0; [1] |
| (2E)-2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [2] | 166900-80-7; [2] | - [2] | |
Look up a number
Type a CAS or EC number, with or without its hyphens, or an Index No into the search box at the top of the page: it reads 50000 as CAS 50-00-0. Every number is also listed by act on the substances page.
Its history
· amended · CLP Annex VI section 3, Index No 616-035-00-5
Recorded in the version in force , by Regulation (EU) 2024/197, the act that change names. The change on its version page
| Identifiers | Version | Index No | Chemical name | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors and ATEs | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||||
| Index No 616-035-00-5CAS 166900-80-7CAS 57966-95-7EC 261-043-0 | Before | 616-035-00-5 | cymoxanil (ISO);
| 261-043-0 | 57966-95-7 | Repr. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361fd
H302
H373 | GHS08 GHS07 GHS09 Wng | H361fd
H302
H373 | M = 1 M = 1 | ||
| After | 616-035-00-5 | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [1] (2E)-2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [2] | 261-043-0[1] - [2] | 57966-95-7[1] 166900-80-7 [2] | Repr. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361fd H302 H373 (blood system, thymus, eyes) H317 H400 H410 | GHS08 GHS07 GHS09 Wng | H361fd H302 H373 (blood system, thymus, eyes) H317 H410 | oral: ATE = 360 mg/kg bw M = 1 M = 1 | |||
· amended · Cosmetics Regulation Annex II, Reference number 1580
Recorded in the version in force , by Regulation (EU) 2025/877, the act that change names. The change on its version page
| Identifiers | Version | Reference number | Substance identification | ||
|---|---|---|---|---|---|
| Chemical name/INN | CAS number | EC number | |||
| a | b | c | d | ||
| Reference number 1580CAS 166900-80-7CAS 57966-95-7EC 261-043-0 | Before | 1580 | |||
| After | 1580 | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [1] | 57966-95-7; [1] | 261-043-0; [1] | |
| (2E)-2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [2] | 166900-80-7; [2] | - [2] | |||
· added · Cosmetics Regulation Annex II, Reference number 1580
Recorded in the version in force , by Regulation (EU) 2019/831 and 5 others, the acts that change names. The change on its version page
| Identifiers | Reference number | Substance identification | ||
|---|---|---|---|---|
| Chemical name/INN | CAS number | EC number | ||
| a | b | c | d | |
| Reference number 1580CAS 57966-95-7EC 261-043-0 | 1580 | Cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 57966-95-7 | 261-043-0 |
· amended · CLP Annex VI section 3, Index No 616-035-00-5
Recorded in the version in force , by Regulation (EU) No 1297/2014 and Regulation (EU) No 605/2014, the acts that change names. The change on its version page
| Identifiers | Version | Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||||
| Index No 616-035-00-5CAS 57966-95-7EC 261-043-0 | Before | 616-035-00-5 | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 261-043-0 | 57966-95-7 | Acute Tox. 4 | H302 H317 H400 H410 | GHS07 GHS09 Wng | H302 H317 H410 | |||
| After | 616-035-00-5 | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 261-043-0 | 57966-95-7 | Repr. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361fd H302 H373 (blood, thymus) H317 H400 H410 | GHS08 GHS07 GHS09 Wng | H361fd H302 H373 (blood, thymus) H317 H410 | M = 1 M = 1 | |||
· amended · CLP Annex VI section 3, table 2, Index No 616-035-00-5
Recorded in the version in force , by Regulation (EU) No 1297/2014 and Regulation (EU) No 605/2014, the acts that change names. The change on its version page
| Identifiers | Version | Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
|---|---|---|---|---|---|---|---|---|---|
| Index No 616-035-00-5CAS 57966-95-7EC 261-043-0 | Before | 616-035-00-5 | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 261-043-0 | 57966-95-7 | Xn; | Xn; N
R: | ||
| After | 616-035-00-5 | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 261-043-0 | 57966-95-7 | Repr. Cat. 3; R62-63 Xn; R22-48/22 R43 N; R50-53 | Xn; N R: 22-43-48/22-62-63-50/53 S: (2-)36/37-46-60-61 | N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % |
Sources
- CLP: every version the record holds; rows read from EUR-Lex consolidated version 02008R1272-20270101, in force 1 January 2027 (external, EUR-Lex)
- Cosmetics Regulation: every version the record holds; rows read from EUR-Lex consolidated version 02009R1223-20260518, in force 18 May 2026 (external, EUR-Lex)